All Stories

  1. Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysis

    Article • Health Economics Review, September 2025, Springer Science + Business Media

    Mr Yubo Wang, Dr Li-Chia Chen

  2. Patient willingness to pay and preference for cervical cancer treatments among middle- and low-income populations in Xinjiang

    Article • Journal of Patient-Reported Outcomes, August 2025, Springer Science + Business Media

    Mr Yubo Wang

  3. Genetic and clinical determinants of MACE and haemorrhage in antiplatelet therapy: insights from pharmacogenomic analysis

    Article • Frontiers in Cardiovascular Medicine, May 2025, Frontiers

    Mr Yubo Wang

  4. Comparative effectiveness of monotherapy vs. combination therapy for postoperative central nervous system infections in neurosurgical patients: a retrospective cohort study

    Article • BMC Infectious Diseases, May 2025, Springer Science + Business Media

    Mr Yubo Wang

  5. Effectiveness and safety of ICIs for the treatment of advanced CC: a systematic review and meta-analysis

    Article • Frontiers in Immunology, March 2025, Frontiers

    Mr Yubo Wang

  6. Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression

    Article • Health and Quality of Life Outcomes, September 2024, Springer Science + Business Media

    Mr Yubo Wang

  7. Investigating adherence to tyrosine kinase inhibitors in renal cancer

    Article • Journal of Oncology Pharmacy Practice, June 2024, SAGE Publications

    Mr Yubo Wang

  8. Survival Outcomes in Older Women with Oestrogen-Receptor-Positive Early-Stage Breast Cancer: Primary Endocrine Therapy vs. Surgery by Comorbidity and Frailty Levels

    Article • Cancers, February 2024, MDPI AG

    Mr Yubo Wang, Dr Li-Chia Chen

  9. The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression

    Article • Health and Quality of Life Outcomes, December 2022, Springer Science + Business Media

    Mr Yubo Wang, Dr Li-Chia Chen

  10. Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer

    Article • Cost Effectiveness and Resource Allocation, March 2022, Springer Science + Business Media

    Mr Yubo Wang, Dr Li-Chia Chen

  11. Evaluating the direct medical cost, drug utilization and expenditure for managing Parkinson’s disease: a costing study at a medical center in China

    Article • Annals of Translational Medicine, March 2022, AME Publishing Company

    Mr Yubo Wang, Dr Li-Chia Chen

  12. Cost-effectiveness analysis of neoadjuvant versus adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer patients during initial treatment phase

    Article • Cost Effectiveness and Resource Allocation, July 2021, Springer Science + Business Media

    Mr Yubo Wang

  13. New perspectives on treatment strategies for patient with acute myeloid leukemia and complex karyotype abnormalities after percutaneous coronary intervention

    Article • Medicine, July 2019, Wolters Kluwer Health

    Mr Yubo Wang

  14. Bridging Ligand Length Controls AT Selectivity and Enantioselectivity of Binuclear Ruthenium Threading Intercalators

    Article • Chemistry - A European Journal, April 2013, Wiley

    Mr Yubo Wang